Marcel Rozencweig
Gründer bei Neotx Holdings Ltd.
Profil
Marcel Rozencweig is the founder of Neotx Holdings Ltd.
He currently serves as the Chairman of Innate Pharma, Inc. Dr. Rozencweig's former positions include Vice President-Oncology & Infectious Diseases at Bristol Myers Squibb Co., Acting Chief Medical Officer at Agenus, Inc., Senior Executive Vice President-Clinical Affairs at Sopherion Therapeutics LLC, and Senior Vice President at GPC Biotech, Inc. He also served as the Executive Vice President & Member-Executive Board at Innate Pharma SA from 2009 to 2017.
Dr. Rozencweig holds a doctorate degree from Université Libre de Bruxelles.
Aktive Positionen von Marcel Rozencweig
| Unternehmen | Position | Beginn |
|---|---|---|
| Innate Pharma, Inc. | Vorsitzender | - |
Neotx Holdings Ltd.
 Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | Gründer | - |
Ehemalige bekannte Positionen von Marcel Rozencweig
| Unternehmen | Position | Ende |
|---|---|---|
| INNATE PHARMA | Technik-/Wissenschafts-/F&E-Leiter | - |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | 01.01.2007 |
| AGENUS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Marcel Rozencweig
| Université Libre de Bruxelles | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AGENUS INC. | Health Technology |
| INNATE PHARMA | Health Technology |
| Private Unternehmen | 4 |
|---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Sopherion Therapeutics LLC
Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Health Technology |
| Innate Pharma, Inc. | |
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | Health Technology |
